TGTX: TG Therapeutics, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 2,025.50
Enterprise Value ($M) 2,033.04
Book Value ($M) 164.77
Book Value / Share 1.14
Price / Book 12.29
NCAV ($M) 148.86
NCAV / Share 1.03
Price / NCAV 13.61

Profitability (mra)
Return on Invested Capital (ROIC) 0.05
Return on Assets (ROA) 0.06
Return on Equity (ROE) 0.22

Liquidity (mrq)
Quick Ratio 5.18
Current Ratio 5.92

Balance Sheet (mrq) ($M)
Current Assets 317.94
Assets 329.59
Liabilities 169.09
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 233.66
Operating Income 20.63
Net Income 12.67
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -31.41
Cash from Investing -50.65
Cash from Financing 72.70

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
02-14 13G/A Darwin Global Management, Ltd. 2.70 -61.28
02-13 13G/A Vanguard Group Inc 9.03 -11.82
01-26 13G/A BlackRock Inc. 7.10 17.91
01-25 13G/A State Street Corp 5.45 -20.75

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-02-29 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023. ☐ TRANSITION REPORT PURSUANT TO SECT
2023-11-06 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2023-08-04 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2023-05-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-04-19 718,685 3,322,399 21.63
2024-04-18 691,012 1,135,657 60.85
2024-04-17 510,039 3,076,512 16.58
2024-04-16 253,856 1,614,576 15.72
2024-04-15 398,285 2,269,304 17.55

(click for more detail)

Similar Companies
TELO – Telomir Pharmaceuticals, Inc. TENX – Tenax Therapeutics, Inc.
TFFP – TFF Pharmaceuticals, Inc. THAR – Tharimmune, Inc.
THTX – Theratechnologies Inc.


Financial data and stock pages provided by
Fintel.io


Finpedia: TG Therapeutics